Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

COSM

Cosmos Health Inc

Feb 10 • 04:00PM ET

0.4212

-0.0039 -0.92 %

Healthcare • Medical Distribution • Greece • NASD

Peers: VRTX OPK CERS MBAI AUPH VNDA HOOK XOMA NNVC

| Held by: VXF

Index	-	P/E	-	EPS (ttm)	-0.71	Insider Own	34.79%	Shs Outstand	31.87M	Perf Week	-10.00%
Market Cap	15.76M	Forward P/E	-	EPS next Y	-0.34	Insider Trans	18.39%	Shs Float	24.41M	Perf Month	-23.40%
Enterprise Value	35.29M	PEG	-	EPS next Q	-0.04	Inst Own	3.26%	Short Float	0.43%	Perf Quarter	-38.96%
Income	-18.54M	P/S	0.26	EPS this Y	-	Inst Trans	2.46%	Short Ratio	0.13	Perf Half Y	-45.79%
Sales	59.79M	P/B	0.58	EPS next Y	-	ROA	-27.67%	Short Interest	0.11M	Perf YTD	-15.42%
Book/sh	0.73	P/C	3.38	EPS next 5Y	62.88%	ROE	-63.82%	52W High	1.32 -68.09%	Perf Year	-41.42%
Cash/sh	0.12	P/FCF	-	EPS past 3/5Y	63.35% 28.41%	ROIC	-63.34%	52W Low	0.28 50.37%	Perf 3Y	-91.46%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-1.09% 6.53%	Gross Margin	9.12%	Volatility	8.39% 11.52%	Perf 5Y	-99.66%
Dividend TTM	-	EV/Sales	0.59	EPS Y/Y TTM	58.81%	Oper. Margin	-22.48%	ATR (14)	0.05	Perf 10Y	-99.67%
Dividend Ex-Date	-	Quick Ratio	0.84	Sales Y/Y TTM	-	Profit Margin	-31.01%	RSI (14)	36.09	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.99	EPS Q/Q	61.57%	SMA20	-12.11%	Beta	4.48	Target Price	4.50
Payout	-	Debt/Eq	1.05	Sales Q/Q	37.86%	SMA50	-14.76%	Rel Volume	0.69	Prev Close	0.43
Employees	149	LT Debt/Eq	0.27	Earnings	Nov 17 BMO	SMA200	-35.08%	Avg Volume	798.18K	Price	0.42
IPO	Jul 23, 2010	Option/Short	Yes / Yes	EPS/Sales Surpr.	- -	Trades		Volume	553,298	Change	-0.92%

Jan-20-26 10:45AM	Cosmos Health Announces Accelerating Customer Growth, Improving Unit Economics and Robotic Expansion Supporting $40M in Additional Annual Revenue (GlobeNewswire) -5.57%
Jan-14-26 11:25AM	Cosmos Health Announces Initiation of Analyst Coverage with $4.50 Valuation by Zacks Small-Cap Research (GlobeNewswire)
Jan-05-26 09:30AM	Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units (GlobeNewswire)
Dec-24-25 09:00AM	Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy (ACCESSWIRE)
Dec-19-25 09:00AM	Cosmos Health is Forcing the Market to Reframe the Conversation (ACCESSWIRE)
12:20PM	Loading…
Dec-03-25 12:20PM	Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets (GlobeNewswire) -10.81%
Dec-02-25 12:15PM	Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases (GlobeNewswire)
Nov-17-25 09:15AM	Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M (GlobeNewswire)
Oct-31-25 10:45AM	Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy (GlobeNewswire) -10.01%
Oct-21-25 12:10PM	Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million (GlobeNewswire)
Oct-16-25 08:00AM	Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire) -12.80%
Oct-13-25 02:05PM	Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million (GlobeNewswire)
Oct-10-25 08:00AM	Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility (GlobeNewswire)
Oct-03-25 03:56PM	Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units (GlobeNewswire)
Sep-29-25 08:00AM	Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation (GlobeNewswire)
08:00AM	Loading…
Sep-25-25 08:00AM	Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL Pessaries Annually (GlobeNewswire)
Sep-22-25 08:00AM	Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue (GlobeNewswire) +15.39%
Sep-11-25 08:00AM	Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units (GlobeNewswire) +10.51%
Aug-18-25 12:45PM	Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025 (GlobeNewswire) -5.27%
Aug-12-25 09:50AM	Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy (GlobeNewswire)
Aug-07-25 09:25AM	Cosmos Health secures $300M financing facility to launch Ethereum strategy (TipRanks) -8.70%
Aug-06-25 09:20AM	Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy (GlobeNewswire) +30.98%
Jun-25-25 11:00AM	Cosmos Health enters U.S. market with DolCas Biotech agreement (TipRanks)
Jun-24-25 10:55AM	Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech (GlobeNewswire)
May-15-25 02:30PM	RETRANSMISSION - Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven (GlobeNewswire)
09:30AM	Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven (GlobeNewswire)
May-07-25 02:30PM	Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units (GlobeNewswire)
May-06-25 01:40PM	Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq (GlobeNewswire)
Apr-30-25 12:50PM	Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000 (GlobeNewswire)
Apr-16-25 12:45PM	Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million (GlobeNewswire)
01:40PM	Loading…
Apr-09-25 01:40PM	Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L (GlobeNewswire)
Apr-08-25 10:45AM	Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order (GlobeNewswire)
Feb-26-25 11:30AM	Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates (ACCESSWIRE)
Feb-18-25 08:30AM	Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1 (ACCESSWIRE)
Feb-11-25 10:15AM	Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market (ACCESSWIRE) -10.28%
Feb-10-25 01:30PM	Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market (ACCESSWIRE)
09:45AM	Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations (ACCESSWIRE)
Feb-07-25 10:00AM	Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility (ACCESSWIRE)
Feb-06-25 03:50PM	Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar (ACCESSWIRE)
Feb-05-25 11:05AM	Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market (ACCESSWIRE)
Jan-28-25 11:00AM	Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow (ACCESSWIRE) -11.39%
Jan-27-25 03:50PM	Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion (ACCESSWIRE)
Jan-23-25 03:35PM	Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait (ACCESSWIRE)
Jan-22-25 08:00AM	Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million (ACCESSWIRE) -17.08%
Jan-21-25 03:00PM	Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days (ACCESSWIRE) +8.47%
Jan-14-25 09:41AM	Cosmos Health secures exclusive distribution agreement with Virax Biolabs (TipRanks) +12.55%
Jan-13-25 09:20AM	Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries (ACCESSWIRE)
Dec-26-24 01:30PM	Cosmos Health Strengthens RandD Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology (ACCESSWIRE)
01:30PM	Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology (ACCESSWIRE)
Dec-23-24 09:25AM	Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000 (ACCESSWIRE) +6.02%
Nov-26-24 09:30AM	Taglich Brothers Releases Updated Coverage on Cosmos Health: Projects Positive EPS for 2025 and Sets $3 Price Target, Nearly 300% Above Current Share Price (ACCESSWIRE)
Nov-18-24 08:00AM	Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets (ACCESSWIRE) +11.13%
Nov-15-24 10:20AM	Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M (ACCESSWIRE)
Nov-12-24 12:00PM	Cosmos Health Issues Letter to Shareholders (ACCESSWIRE) +7.09%
Nov-01-24 12:30PM	Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21% (ACCESSWIRE) -5.32%
Sep-25-24 09:25AM	Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands (ACCESSWIRE) -10.27%
Sep-23-24 12:55PM	Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins (ACCESSWIRE) -8.18%
09:00AM	Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits (ACCESSWIRE)
Sep-19-24 03:40PM	Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion (ACCESSWIRE)
Sep-18-24 01:30PM	Cosmos Health Releases 2024-2027 Updated Guidance; Projects Revenue of $155.8M and Adjusted EBITDA of $29.4M Annually by 2027, Driven by Strategic Focus on High-Margin Segments (ACCESSWIRE)
Sep-17-24 11:45AM	Taglich Brothers Publishes Updated Coverage Report on Cosmos Health; Maintains Price Target of $4, Nearly 300% Above Current Share Price (ACCESSWIRE) +13.43%
Sep-16-24 08:30AM	Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc. (PR Newswire)
08:30AM	Cosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and Qatar (ACCESSWIRE)
Aug-23-24 09:35AM	Cosmos Health Regains Full Compliance with Nasdaq Listing Requirements (ACCESSWIRE)
Aug-21-24 10:20AM	Cosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits (ACCESSWIRE) +17.76%
Aug-20-24 12:20PM	Cosmos Health Reports Q2 2024 Results: Sustains Positive Momentum with 7% Revenue Growth vs. Q1 2023 and 12.5% vs. H1 2023 (ACCESSWIRE) -15.08%
09:00AM	Cosmos Health Reports Q1 2024 Results: Continues to Deliver Strong Growth and Improved Performance with 18% YoY Revenue Increase and 39% Rise in Gross Profit (ACCESSWIRE)
Aug-08-24 01:00PM	Cosmos Health Completes Registration Process in Germany to Commence Sales of its C-Scrub Antimicrobial Wash; Enters $750M+ Market (ACCESSWIRE)
Aug-06-24 09:00AM	Cosmos Health Reports Full Year 2023 Results: Revenue Increases to $53.4M, or 6% YoY; Stockholders' Equity Remains Near Record Highs at $36M, or $2.25 per Share (ACCESSWIRE) +15.00%
Jul-25-24 02:45PM	Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland (ACCESSWIRE) +5.79%
11:40AM	Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar (ACCESSWIRE)
Jul-24-24 10:55AM	Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity (ACCESSWIRE)
Jul-19-24 11:40AM	Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule (ACCESSWIRE)
Jul-18-24 03:45PM	Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units (ACCESSWIRE) -10.36%
Jul-10-24 03:45PM	Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market (ACCESSWIRE)
Jul-09-24 02:00PM	Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually (ACCESSWIRE)
Jul-03-24 01:05PM	Cosmos Health's Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement with Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE (ACCESSWIRE) -10.89%
Jul-02-24 03:30PM	Cosmos Health Expands Collaboration with Papaellinas in Cyprus; Sky Premium Life Sales Expected to More Than Double to 150,000 Units Over Next 12 Months (ACCESSWIRE) -8.18%
Jul-01-24 11:20AM	Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains (ACCESSWIRE) +5.77%
Jun-28-24 08:12AM	Why Is Cosmos Health (COSM) Stock Up 65% Today? (InvestorPlace) +53.17%
07:39AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jun-27-24 03:45PM	Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units (ACCESSWIRE) +5.27%
Jun-18-24 10:00AM	Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent (ACCESSWIRE)
Jun-13-24 09:25AM	Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million (ACCESSWIRE)
May-24-24 04:30PM	Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of Its Forms 10-K and 10-Q (ACCESSWIRE) +5.87%
May-17-24 10:15AM	Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand (ACCESSWIRE)
Apr-30-24 09:42AM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Healthcare Stocks (InvestorPlace)
Apr-19-24 04:30PM	Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K (ACCESSWIRE) -20.39%
Mar-21-24 09:45AM	Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform (ACCESSWIRE) -7.78%
Mar-19-24 10:10AM	Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market (ACCESSWIRE)
Mar-18-24 09:25AM	Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders (ACCESSWIRE) -5.34%
Feb-29-24 09:25AM	Cosmos Health Successfully Completes Acquisition of Pharmatrade's Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million (ACCESSWIRE)
Feb-23-24 12:00AM	As Trading Frenzies Grip Penny Stocks, Criticism of Nasdaq Grows (The Wall Street Journal)
Feb-21-24 11:50AM	Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price (ACCESSWIRE)
09:30AM	Taglich Brothers Initiates Coverage of Cosmos Health Inc. (GlobeNewswire)
Feb-20-24 09:25AM	Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company (ACCESSWIRE)
Feb-01-24 09:25AM	Taglich Brothers Initiates Coverage of Cosmos Health Inc. (ACCESSWIRE)
Jan-23-24 01:05PM	Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market (ACCESSWIRE)
Jan-18-24 09:25AM	Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio (ACCESSWIRE)
Dec-27-23 09:27AM	Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023 (ACCESSWIRE) +10.07%

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Thessaloniki, Greece.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Siokas Grigorios	Chief Executive Officer	Jan 23 '26	Buy	0.50	90,325	45,000	8,182,120	Jan 26 11:48 AM
Siokas Grigorios	Chief Executive Officer	Jan 20 '26	Buy	0.50	353,321	175,000	8,091,795	Jan 21 10:11 AM
Siokas Grigorios	Chief Executive Officer	Jan 14 '26	Buy	0.45	493,495	220,000	7,738,474	Jan 15 09:40 AM
Siokas Grigorios	Chief Executive Officer	Jan 12 '26	Buy	0.50	113,185	57,000	7,244,979	Jan 13 10:00 AM
Siokas Grigorios	Chief Executive Officer	Jan 08 '26	Buy	0.52	156,190	81,000	7,131,794	Jan 09 11:43 AM
Siokas Grigorios	Chief Executive Officer	Jan 07 '26	Buy	0.52	124,880	65,000	6,975,604	Jan 08 10:41 AM
Siokas Grigorios	Chief Executive Officer	Jan 06 '26	Buy	0.54	133,953	72,000	6,850,724	Jan 07 01:01 PM
Siokas Grigorios	Chief Executive Officer	Dec 19 '25	Buy	0.49	88,314	43,000	6,716,771	Dec 22 10:45 AM
Siokas Grigorios	Chief Executive Officer	Dec 15 '25	Buy	0.42	168,472	70,000	6,628,457	Dec 16 12:17 PM
Siokas Grigorios	Chief Executive Officer	Nov 28 '25	Buy	0.64	76,360	49,000	6,459,985	Dec 01 12:02 PM
Siokas Grigorios	Chief Executive Officer	Nov 25 '25	Buy	0.63	55,732	35,000	6,383,625	Nov 26 12:52 PM
Siokas Grigorios	Chief Executive Officer	Nov 21 '25	Buy	0.68	56,080	38,000	6,327,893	Nov 24 02:47 PM
Siokas Grigorios	Chief Executive Officer	Nov 20 '25	Buy	0.62	51,315	32,000	6,271,813	Nov 21 10:07 AM
Siokas Grigorios	Chief Executive Officer	Nov 19 '25	Buy	0.65	61,614	40,000	6,220,498	Nov 20 11:06 AM
Siokas Grigorios	Chief Executive Officer	May 23 '25	Buy	0.45	34,004	15,217	6,158,884	May 27 09:33 AM
Siokas Grigorios	Chief Executive Officer	May 22 '25	Buy	0.44	141,825	62,800	6,124,880	May 23 12:18 PM
Siokas Grigorios	Chief Executive Officer	May 21 '25	Buy	0.47	174,172	82,000	5,983,055	May 22 10:33 AM
Siokas Grigorios	Chief Executive Officer	May 20 '25	Buy	0.45	147,563	65,961	5,808,883	May 21 10:20 AM
Siokas Grigorios	Chief Executive Officer	May 19 '25	Buy	0.43	79,254	34,000	5,661,320	May 20 09:51 AM
Siokas Grigorios	Chief Executive Officer	Apr 24 '25	Buy	0.40	254,618	102,000	5,582,066	Apr 28 10:49 AM
Siokas Grigorios	Chief Executive Officer	Apr 24 '25	Buy	0.40	177,234	71,000	5,327,448	Apr 25 10:07 AM
Siokas Grigorios	Chief Executive Officer	Apr 23 '25	Buy	0.40	205,000	82,000	5,150,214	Apr 24 09:48 AM
Siokas Grigorios	Chief Executive Officer	Apr 22 '25	Buy	0.36	175,000	63,000	4,945,214	Apr 23 10:43 AM
Siokas Grigorios	Chief Executive Officer	Apr 21 '25	Buy	0.32	654,912	208,000	4,770,214	Apr 22 09:59 AM
Siokas Grigorios	Chief Executive Officer	Mar 04 '25	Buy	0.53	85,714	45,000	4,115,302	Mar 05 11:05 AM
Siokas Grigorios	Chief Executive Officer	Mar 03 '25	Buy	0.49	132,572	65,000	4,029,588	Mar 04 12:32 PM
Siokas Grigorios	Chief Executive Officer	Feb 24 '25	Buy	0.56	354,296	200,000	3,897,016	Feb 25 09:49 AM

Open in Screener

ADC

Agree Realty Corp

Feb 10 • 04:00PM ET

76.51

+1.21 1.61 %

Real Estate • REIT - Retail • USA • NYSE

Peers: O NNN WPC EPRT GTY FRT KIM ROIC REG KRG

| Held by: VNQ IJH VTI VB VBR VXF MDY SCHH SCHA SPMD

Index	-	P/E	44.76	EPS (ttm)	1.71	Insider Own	1.81%	Shs Outstand	114.13M	Perf Week	5.97%
Market Cap	8.79B	Forward P/E	37.95	EPS next Y	2.02	Insider Trans	3.80%	Shs Float	112.85M	Perf Month	8.51%
Enterprise Value	12.40B	PEG	9.12	EPS next Q	0.48	Inst Own	113.68%	Short Float	4.77%	Perf Quarter	4.22%
Income	185.67M	P/S	12.76	EPS this Y	10.37%	Inst Trans	1.13%	Short Ratio	4.49	Perf Half Y	5.00%
Sales	688.94M	P/B	1.53	EPS next Y	3.19%	ROA	2.19%	Short Interest	5.38M	Perf YTD	6.22%
Book/sh	49.92	P/C	520.95	EPS next 5Y	4.16%	ROE	3.47%	52W High	79.65 -3.94%	Perf Year	5.08%
Cash/sh	0.15	P/FCF	18.33	EPS past 3/5Y	-0.08% -1.65%	ROIC	2.17%	52W Low	68.98 10.92%	Perf 3Y	5.27%
Dividend Est.	3.18 (4.16%)	EV/EBITDA	21.97	Sales past 3/5Y	22.09% 26.92%	Gross Margin	53.99%	Volatility	2.39% 1.94%	Perf 5Y	15.64%
Dividend TTM	3.09 (4.04%)	EV/Sales	17.99	EPS Y/Y TTM	-5.17%	Oper. Margin	47.87%	ATR (14)	1.44	Perf 10Y	112.12%
Dividend Ex-Date	Feb 27, 2026	Quick Ratio	0.17	Sales Y/Y TTM	14.67%	Profit Margin	26.95%	RSI (14)	65.45	Recom	1.75
Dividend Gr. 3/5Y	4.89% 5.64%	Current Ratio	0.17	EPS Q/Q	7.87%	SMA20	4.85%	Beta	0.53	Target Price	81.58
Payout	168.60%	Debt/Eq	0.59	Sales Q/Q	18.49%	SMA50	5.44%	Rel Volume	1.08	Prev Close	75.30
Employees	75	LT Debt/Eq	0.45	Earnings	Feb 10 AMC	SMA200	4.52%	Avg Volume	1.20M	Price	76.51
IPO	Apr 15, 1994	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.06% 2.57%	Trades		Volume	1,297,314	Change	1.61%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-11-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$75
May-07-25	Downgrade	BTIG Research	Buy → Neutral
Mar-04-25	Upgrade	Barclays	Underweight → Equal Weight	$74 → $75
Dec-17-24	Initiated	Barclays	Underweight	$76
Dec-17-24	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Dec-12-24	Initiated	Evercore ISI	Outperform	$82
Dec-11-24	Initiated	Deutsche Bank	Buy	$88
May-31-24	Initiated	UBS	Neutral	$60
Feb-13-24	Initiated	BMO Capital Markets	Outperform	$69
Jan-22-24	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$71
Dec-13-23	Downgrade	Exane BNP Paribas	Outperform → Neutral	$64
Dec-11-23	Downgrade	Mizuho	Buy → Neutral	$67 → $61
Sep-21-23	Initiated	Wells Fargo	Overweight	$70
Jun-22-23	Upgrade	Mizuho	Neutral → Buy	$70
Jun-14-23	Initiated	Exane BNP Paribas	Outperform	$80
Mar-21-23	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-23-22	Initiated	Credit Suisse	Outperform	$78
Jun-02-22	Upgrade	BofA Securities	Neutral → Buy	$76 → $78
May-10-22	Initiated	JMP Securities	Mkt Outperform	$81
Apr-01-22	Initiated	Morgan Stanley	Overweight	$75

Show Previous Ratings

Today 07:00PM	Agree Realty (ADC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
05:25PM	Agree Realty (ADC) Q4 FFO and Revenues Top Estimates (Zacks)
04:32PM	Agree Realty: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Agree Realty Corporation Reports Fourth Quarter and Full Year 2025 Results (Business Wire)
Feb-05-26 05:55PM	Phillips Edison & Company, Inc. (PECO) Matches Q4 FFO Estimates (Zacks)
04:05PM	Loading…
04:05PM	Agree Realty Declares Monthly Common and Preferred Dividends (Business Wire)
Feb-03-26 04:20PM	RBC Capital Says Agree Realty Corporation (ADC)'s Q4 Deal Activity Remains Within Guidance (Insider Monkey)
Jan-30-26 10:44AM	Realty Income Gains 7.8% in a Month: What Should Investors Do? (Zacks)
Jan-15-26 12:21PM	Monthly Payouts & Expanding Reach: Can Realty Income Deliver? (Zacks)
Jan-13-26 04:05PM	Agree Realty Declares Monthly Common and Preferred Dividends (Business Wire)
Jan-12-26 08:55AM	How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings (Zacks)
Jan-08-26 06:04AM	Insiders Put $1 Million on the Line in These 2 Stocks Why It Could Pay to Follow Their Move (TipRanks)
Jan-06-26 04:35PM	3 Stocks That Cut You a Check Each Month (Motley Fool)
04:12PM	Agree Realty Announces Fourth Quarter 2025 Earnings Release Date and Conference Call Information (Business Wire)
10:24AM	How Agree Realty's $1.55B 2025 Investments Shape Its 2026 Outlook (Zacks)
08:55AM	Loading…
08:55AM	These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Jan-05-26 04:05PM	Agree Realty Announces 2025 Investment Activity & 2026 Investment Outlook (Business Wire)
Dec-29-25 10:51AM	Is Realty Income's 5.7% Yield Attractive Enough to Buy the Stock Now? (Zacks)
Dec-28-25 08:35PM	The Smartest Dividend Stocks to Buy With $1,000 Right Now (Motley Fool)
Dec-27-25 12:10AM	Mizuho Modestly Adjusts Valuation on Agree Realty (ADC) (Insider Monkey)
Dec-24-25 08:12AM	Boomers Are Buying These 5 High-Quality Monthly Dividend Stocks Hand Over Fist (24/7 Wall St.)
Dec-18-25 04:05PM	Agree Realty Publishes Fifth Annual Sustainability Report (Business Wire)
Dec-12-25 07:46PM	2 Stocks That Cut You a Check Each Month (Motley Fool)
Dec-11-25 04:05PM	Agree Realty Declares Monthly Common and Preferred Dividends (Business Wire)
10:41AM	Crypto Market 2026 Predictions: Which Coins Will 10x and Which Will Crash? (24/7 Wall St.)
10:41AM	Boomers Looking for Passive Income Can Buy 5 Safe High-Yield Monthly Income Stocks (24/7 Wall St.)
Dec-10-25 09:22AM	Realty Income Hikes Dividend Again: Can It Sustain Its Market Edge? (Zacks)
Dec-04-25 10:00PM	Here's How You Can Earn $100 In Passive Income By Investing In Agree Realty Stock (Benzinga)
05:03PM	Wall Street Sees a 22% Upside to Agree Realty Corporation (ADC) (Insider Monkey)
Nov-30-25 08:00AM	How Philip Morris, Rexford Industrial Realty, And Agree Realty Can Put Cash In Your Pocket (Benzinga)
10:24AM	Loading…
Nov-26-25 10:24AM	Buy, Hold or Sell Realty Income Amid Rising Fed Rate Cut Expectations? (Zacks)
Nov-21-25 03:35PM	5 Passive Income Monthly Pay Dividend All-Stars Every Boomer Should Own (24/7 Wall St.)
08:53AM	Monthly Payouts and Expanding Portfolio: Can Realty Income Deliver? (Zacks)
Nov-18-25 04:05PM	Agree Realty Closes $350 Million 5.5-Year Delayed Draw Term Loan (Business Wire)
Nov-11-25 04:05PM	Agree Realty Declares Monthly Common and Preferred Dividends (Business Wire)
Nov-05-25 09:32AM	Zacks Industry Outlook Highlights Agree Realty, Federal Realty Investment Trust and Urban Edge Properties (Zacks)
Nov-04-25 10:00AM	Bet on These 3 Retail REITs as the Sector Shows Renewed Strength (Zacks)
Oct-31-25 01:59PM	Is Realty Income Stock a Buy, Hold, or Sell Before Q3 Earnings? (Zacks)
04:05AM	Retirees: These 2 Reliable Dividend Stocks Could Pay You Every Month (Motley Fool)
Oct-28-25 08:01AM	Looking For Yields: Black Hills, Genuine Parts, And Agree Realty Are Consistent Moneymakers (Benzinga)
Oct-26-25 04:25AM	Best Stock to Buy Right Now: Costco vs. Agree (Motley Fool)
Oct-24-25 11:49AM	Realty Income Stock: Buy, Hold or Sell This High-Yield Dividend Play? (Zacks)
Oct-22-25 03:03PM	Agree Realty Corp (ADC) Q3 2025 Earnings Call Highlights: Record Investment Volume and Strong ... (GuruFocus.com)
11:31AM	Can Realty Income Sustain Growth While Paying Monthly Dividends? (Zacks)
Oct-21-25 06:30PM	Agree Realty (ADC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
06:20PM	Agree Realty (ADC) Surpasses Q3 FFO and Revenue Estimates (Zacks)
05:19PM	Agree Realty: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Agree Realty Corporation Reports Third Quarter 2025 Results (Business Wire)
Oct-20-25 09:15AM	What Analyst Projections for Key Metrics Reveal About Agree Realty (ADC) Q3 Earnings (Zacks)
Oct-17-25 09:45AM	Insiders Bet Big on These 3 Fintech and Biotech Stocks (24/7 Wall St.)
Oct-15-25 07:35AM	Meet the Little-Known Company Yielding 4.2% That Continues to Deliver Monthly for Income Seekers and Is Making Patient Investors Notably Richer (Motley Fool)
Oct-14-25 04:05PM	Agree Realty Declares Increased Monthly Common Dividend (Business Wire)
Oct-11-25 08:01AM	If You Invested $10K In Agree Realty Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
Oct-08-25 11:22AM	Agree Realty Corporation (ADC): A Bull Case Theory (Insider Monkey)
Oct-02-25 01:10PM	The Appeal of Agree Realty Corporation (ADC) for Long-Term Investors in REIT Dividend Stocks (Insider Monkey)
Sep-30-25 04:05PM	Agree Realty Announces Third Quarter 2025 Earnings Release Date and Conference Call Information (Business Wire)
Sep-27-25 01:35PM	4 Monthly Dividend Stocks Yielding 4% or More to Buy Right Now for Passive Income (Motley Fool)
Sep-24-25 11:27PM	Safest Monthly Dividend Stocks: Agree Realty Corporation's (ADC) Strength in Industrial Real Estate (Insider Monkey)
09:05AM	Can O Stock Keep Climbing After Delivering 11.6% YTD Growth in 2025? (Zacks)
Sep-23-25 12:35PM	Can Realty Income Hold On to Its Dividend Strength & Global Growth? (Zacks)
Sep-19-25 08:48PM	Why Long-Term Investors Favor Agree Realty Corporation (ADC) in Dividend Stocks to Buy Under $100 (Insider Monkey)
Sep-12-25 10:51AM	5 Reasons to Add VICI Properties Stock to Your Portfolio Now (Zacks)
Sep-11-25 08:01AM	Why Agree Realty, Open Text, And Comcast Are Winners For Passive Income (Benzinga)
Sep-10-25 12:00PM	Agree Realty (ADC) Moves to Buy: Rationale Behind the Upgrade (Zacks)
10:43AM	Realty Income Boosts Dividend: Can It Preserve Investor Appeal? (Zacks)
Sep-09-25 04:05PM	Agree Realty Declares Monthly Common and Preferred Dividends (Business Wire)
05:10AM	10 Dividend Stocks to Hold for the Next 10 Years (Motley Fool)
Aug-28-25 11:16AM	Is Realty Income Stock a Buy, Hold or Sell Amid Fed Rate Cut Hopes? (Zacks)
Aug-22-25 04:05AM	Best Stock to Buy Right Now: Realty Income vs. Agree Realty (Motley Fool)
Aug-21-25 12:00PM	Monthly Payouts and Expanding Portfolio: Can Realty Income Deliver? (Zacks)
Aug-18-25 07:30AM	Agree Realty Announces the Addition of Kirk Klatt as Vice President of Leasing (Business Wire)
Aug-12-25 04:05PM	Agree Realty Declares Monthly Common and Preferred Dividends (Business Wire)
08:30AM	Agree Realty Achieves A- Credit Rating From Fitch Ratings (Business Wire)
07:19AM	Should You Be Optimistic on Agree Realty Corporation's (ADC) Long-Term Prospects? (Insider Monkey)
Aug-07-25 05:35AM	2 Stocks That Cut You a Check Each Month (Motley Fool)
Aug-06-25 08:01AM	How Chevron, Agree Realty, And Essential Utilities Can Put Cash In Your Pocket (Benzinga)
Aug-05-25 11:46AM	Should You Buy, Hold or Sell Realty Income Stock Ahead of Q2 Earnings? (Zacks)
Aug-04-25 06:10AM	Better Dividend Stock: Sun Communities vs. Agree Realty (Motley Fool)
Aug-02-25 03:09AM	Agree Realty Corp (ADC) Q2 2025 Earnings Call Highlights: Robust Investment Growth and ... (GuruFocus.com)
Jul-31-25 06:30PM	Agree Realty (ADC) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
05:40PM	Agree Realty (ADC) Matches Q2 FFO Estimates (Zacks)
04:41PM	Agree Realty: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Agree Realty Corporation Reports Second Quarter 2025 Results (Business Wire)
Jul-29-25 08:50AM	Why Investors Need to Take Advantage of These 2 Finance Stocks Now (Zacks)
Jul-24-25 05:30PM	Phillips Edison & Company, Inc. (PECO) Q2 FFO and Revenues Beat Estimates (Zacks)
Jul-22-25 10:18AM	Is Realty Income Stock's 5.7% Dividend Yield Enough to Drive a Buy? (Zacks)
Jul-21-25 05:30AM	Prediction: 2 Stocks That Will Be Worth More Than Annaly Capital 5 Years From Now (Motley Fool)
Jul-12-25 04:06AM	3 Stocks That Cut You a Check Each Month (Motley Fool)
Jul-10-25 04:05PM	Agree Realty Declares Monthly Common and Preferred Dividends (Business Wire)
02:22PM	Agree Realty Corporation (ADC): A Bull Case Theory (Insider Monkey)
11:16AM	If You Invested $10K In Agree Realty Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
Jul-09-25 08:50AM	These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Jul-08-25 08:50AM	How to Find Strong Finance Stocks Slated for Positive Earnings Surprises (Zacks)
Jul-06-25 06:45AM	2 Top Dividend Stocks to Buy in July (Motley Fool)
Jun-30-25 04:05PM	Agree Realty Announces Second Quarter 2025 Earnings Release Date and Conference Call Information (Business Wire)
09:23AM	Strength Seen in Equinix (EQIX): Can Its 5.3% Jump Turn into More Strength? (Zacks)
Jun-26-25 04:44PM	Should Dividend Investors Stick with Agree Realty Corporation in this Environment (Insider Monkey)
Jun-24-25 10:42AM	Should You Hold Onto O Stock in 2025 Beyond Its 9% YTD Growth? (Zacks)
Jun-18-25 04:25AM	??3 Stocks That Cut You a Check Each Month (Motley Fool)
Jun-13-25 11:55AM	VICI Properties Rises 12.7% Year to Date: Should You Buy or Sell? (Zacks)

Agree Realty Corp. is a real estate investment trust, which engages in the ownership, acquisition, development, and management of retail properties net leased to industry tenants. It focuses on the long-term, fee simple ownership of properties net leased to national and large regional retailers. The company was founded by Richard Agree in 1971 and is headquartered in Royal Oak, MI.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Coughenour Peter	CHIEF FINANCIAL OFFICER	Jan 09 '26	Buy	69.80	500	34,900	18,544	Jan 13 06:59 AM
AGREE RICHARD	EXECUTIVE CHAIRMAN OF BOARD	Jan 09 '26	Buy	70.67	24,000	1,696,080	159,855	Jan 12 07:09 AM
RAKOLTA JOHN JR	Director	Dec 24 '25	Buy	72.18	15,000	1,082,700	562,606	Dec 29 04:30 PM
RAKOLTA JOHN JR	Director	Oct 07 '25	Buy	70.41	25,154	1,771,093	553,700	Oct 09 04:05 PM
Erlich Craig	CHIEF GROWTH OFFICER	Oct 03 '25	Buy	70.84	360	25,504	52,846	Oct 06 06:30 AM
Agree Joey	PRESIDENT & CEO	Oct 02 '25	Buy	70.63	3,528	249,183	638,688	Oct 03 06:30 AM
Lehmkuhl Greg	Director	Sep 05 '25	Buy	72.84	750	54,630	27,684	Sep 08 06:30 AM
Agree Joey	PRESIDENT & CEO	Aug 14 '25	Buy	72.08	2,100	151,368	635,160	Aug 18 06:30 AM
Agree Joey	PRESIDENT & CEO	Aug 13 '25	Buy	72.15	4,108	296,392	633,060	Aug 14 06:15 AM
Agree Joey	PRESIDENT & CEO	Aug 13 '25	Buy	72.15	742	53,535	2,934	Aug 14 06:15 AM
RAKOLTA JOHN JR	Director	Jun 11 '25	Buy	74.34	10,000	743,400	521,233	Jun 13 06:00 AM
RAKOLTA JOHN JR	Director	Apr 08 '25	Buy	71.30	28,080	2,002,104	507,810	Apr 10 06:30 AM

COSM

Cosmos Health Inc

ADC

Agree Realty Corp

Upgrade your FINVIZ experience